R. Terry Hisey

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

127

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

The Follow-On Biologics Market: Enter at Your Own Risk

Number of pages: 18 Posted: 08 Dec 2011
Anjan Chatterji, R. Terry Hisey, Rob Jacoby and Ted Hoffman
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 127 (232,131)

Abstract:

Loading...

generics, follow-on biologics, biosimilars, interchangeablility, FDA, biologics, innovation, incumbent, BLA, NDA, Biologics Price Competition and Innovation Act, 2010 Patient Protection and Affordable Care Act, Data Exclusivity, patents